Ask AI
ProCE Banner Activity

CE

Elevating Tardive Dyskinesia Detection and Care: Comprehensive Strategies for APP

Video

Early recognition of tardive dyskinesia requires healthcare professionals to identify subtle or easily overlooked movements that can affect physical functioning, psychological well-being, social engagement, and treatment adherence. This expert-led webcast explores strategies for identifying patients at risk, incorporating structured AIMS assessments into practice, differentiating TD from other drug-induced movement disorders, evaluating TD-related functional and quality-of-life impact, and evidence-based treatment approaches including VMAT2 inhibitors.

Nurse Practitioners/Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Released: October 20, 2026

Expiration: October 19, 2027

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Neurocrine Biosciences.

Neurocrine Biosciences

Target Audience

This educational activity is intended for nurse practitioners, physician associates, and other healthcare professionals who treat patients or advise HCP care teams regarding their patients with tardive dyskinesia who may benefit from this education.

Program Learning Goal

The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Movement Disorders.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recognize patient- and treatment-related risk factors for tardive dyskinesia across adult populations

  • Implement routine TD screening using validated assessment tools, such as the Abnormal Involuntary Movement Scale (AIMS), to support early identification and ongoing monitoring within clinical workloads

  • Apply evidence-based, patient-centered approaches to TD management and referral, incorporating shared decision-making, collaboration with specialists, and consideration of functional impact and psychiatric stability

Financial Disclosures

Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Zach Aldridge, PMHNP: consultant/advisor/speaker: Neurocrine.

Jeremy Schreiber, MSN, APRN, PMHNP-BC: consultant/advisor/speaker: Alkermes, Axsome, Biogen, Bristol Myers Squibb, Intra-Cellular, Janssen, Johnson & Johnson, Neurocrine, Sage, Supernus, Teva, Vanda; individual publicly traded stocks/stock options: Biogen, Bristol Myers Squibb, Sage.

The planners and content peer reviewers from Decera Clinical Education do not have any relevant financial relationships to disclose, except Amanda Zimmerman, PA-C as noted below:

Amanda Zimmerman, PA-C: consultant/advisor/speaker: Vertex.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from October 20, 2026, through October 19, 2027:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Additional Disclosures

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour, including 1 hour of pharmacotherapy credit.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until October 19, 2027. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation

A logo for a credit companyAI-generated content may be incorrect.

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credits for learning and change.